CA
NZ
UK
AU
IND
US
La-Z-Boy Incorporated filed its Form 10-Q for the quarterly period ended July 25, 2026 with the Securities and Exchange Commission on August 18, 2026, covering the first quarter of fiscal year 2027.
ConnectOne Bancorp, Inc. filed a Form 10-Q/A (Amendment No. 1) on August 18, 2026, amending its quarterly report for the period ended June 30, 2026, solely to correct a clerical error in the reported number of common shares outstanding on the original filing's cover …
Director Laura A. Sugg filed a statement of changes in beneficial ownership with the SEC on August 18, 2026, reporting the sale of Class A Common Stock in Kinetik Holdings Inc. (NYSE:KNTK) on August 14, 2026.
A statement of changes in beneficial ownership filed on August 18, 2026 reports that Scott M. Ferris, a director of First Business Financial Services, Inc., acquired 575 shares of common stock on August 16, 2026.
Tim James O'Brien, Executive Vice President and Chief Financial Officer of N-able, Inc. (NYSE:NABL), filed a Form 4 on August 18, 2026, disclosing a transaction in the company's common stock dated August 15, 2026.
Joel S. Goldberg, Senior Vice President, Administration, General Counsel and Secretary of Revvity, Inc. (NYSE:RVTY), filed a statement of changes in beneficial ownership on August 18, 2026, reporting a gift transaction in Revvity common stock dated August 14, 2026.
Peter C. Anastos, Executive Vice President, General Counsel, and Secretary of N-able, Inc. (NYSE:NABL), filed a Form 4 on August 18, 2026, disclosing a transaction in the company's common stock dated August 15, 2026.
A Form 4 filed on August 18, 2026, discloses that Michael I. Adler, Executive Vice President and Chief Technology and Product Officer of N-able, Inc. (NYSE:NABL), disposed of 4,586 shares of common stock on August 15, 2026, to satisfy tax withholding obligations tied to …
Paul F. Lizzul, Chief Medical Officer of First Tracks Biotherapeutics, Inc. (NASDAQ:TRAX), filed a Form 4 on August 18, 2026, reporting the acquisition of 60,492 performance-based restricted stock units earned upon certification of performance criteria on August 15, 2026.
Benjamin Stone, Chief Business Officer of First Tracks Biotherapeutics, Inc. (NASDAQ:TRAX), filed a Form 4 on August 18, 2026, disclosing the award of 60,492 performance stock units earned upon certification of achieved performance criteria on August 15, 2026.
Please wait processing your request...